8-K - Jasper Therapeutics, Inc. (0001788028) (Filer)
Published . Updated .
Filed: 2026-10-07 AccNo: 0001213900-26-107402 Size: 238 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Directly affected
- JSPR Jasper Therapeutics
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-07 AccNo: 0001213900-26-107402 Size: 238 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
How far Jasper Therapeutics (JSPR) has moved since 7 Oct 2026
Since the first closing price after “8-K - Jasper Therapeutics, Inc. (0001788028) (Filer),” Jasper Therapeutics (JSPR) is -15.01%. The S&P 500 fund (SPY) is -0.94% over the same days, a -14.07% difference versus the market.
Who gains and who loses around Jasper Therapeutics (JSPR)
Companies mentioned with this story
- JSPR Jasper Therapeutics
Jasper Therapeutics (JSPR) is linked, with no stored direction, high confidence in the 7 Oct 2026 story “8-K - Jasper Therapeutics, Inc. (0001788028) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> JSPR
How “8-K - Jasper Therapeutics, Inc. (0001788028) (Filer)” reaches Jasper Therapeutics (JSPR)
Jasper Therapeutics (JSPR) is the company in “8-K - Jasper Therapeutics, Inc. (0001788028) (Filer),” the 7 Oct 2026 this story story.
The link for Jasper Therapeutics (JSPR) is this: SEC 8-K filing -> direct issuer disclosure -> JSPR
Dates and price levels for Jasper Therapeutics (JSPR)
JSPR traded between 0.46 and 0.61 across 12 sessions. The latest close on file is 0.48.
How solid “8-K - Jasper Therapeutics, Inc. (0001788028) (Filer)” looks
14 out of 100
“8-K - Jasper Therapeutics, Inc. (0001788028) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.